Aristeia Capital’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Aristeia Capital’s Portfolio CLDI.WS Stock Details CLDI.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-494,400	Closed	-$6.9K	–	495
2024 Q3	$6.9K	Hold	494,400	–	–	﹤0.01%	341
2024 Q2	$17.3K	Hold	494,400	–	–	﹤0.01%	284
2024 Q1	$27.2K	Hold	494,400	–	–	﹤0.01%	222
2023 Q4	$31.9K	Hold	494,400	–	–	﹤0.01%	125
2023 Q3	$116K	Hold	494,400	–	–	﹤0.01%	99
2023 Q2	$59K	Hold	494,400	–	–	﹤0.01%	153
2023 Q1	$24.3K	Sell	494,400 -600	-0.1%	-$47	﹤0.01%	294
2022 Q4	$24.8K	Hold	495,000	–	–	﹤0.01%	395
2022 Q3	$26K	Hold	495,000	–	–	﹤0.01%	544
2022 Q2	$47K	Hold	495,000	–	–	﹤0.01%	518
2022 Q1	$165K	Buy	+495,000	New	+$218K	﹤0.01%	472

Other funds holding CLDI.WS

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

Aristeia Capital's CLDI.WS Position: Q4 2024 in Review

Aristeia Capital sold out of Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 (CLDI.WS) in Q4 2024, closing a stake of 494,400 shares — an estimated $6.9K sold.

Aristeia Capital first reported a position in CLDI.WS in Q1 2022 and held it in 11 quarters. The position peaked at $165K in Q1 2022. 1 fund tracked by Wall St. Rank holds CLDI.WS as of Q4 2024.

Aristeia Capital reported no remaining Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 position as of Q4 2024 after selling out during the quarter.
Aristeia Capital sold 494,400 Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 shares in Q4 2024, an estimated $6.9K.
Aristeia Capital first reported a position in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in Q1 2022 and held it in 11 quarters.
Aristeia Capital's Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 position peaked at $165K in Q1 2022.
1 fund tracked by Wall St. Rank held Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 as of Q4 2024.

Based on Aristeia Capital's 13F filing for Q4 2024, filed 14 Feb 2025.